Araújo et al. (2017),32 Queiroz (2016),33 and Queiroz et al. (2019)34
|
Adolescents (136) |
Brown (62%) |
NR (Excluded some conditions)a
|
NR/None |
Normal weight (72%) |
17 (±SD 1)b
|
Benaim et al. (2019)59
|
Pregnant women (181) |
Mixed (47%) |
NR (Excluded some conditions)c
|
NR/Yes |
Median: 24 (IQR 22–27) |
Median: 26 (IQR 22–31) |
Chrisostomo et al. (2018)38
|
Pregnant women (520) |
Euro-descendant (52%) |
Preeclampsia; GDM; HIV+ |
Antiretroviral/None |
Median 31 (IQR: 27; 35) |
Median: 30 (IQR: 25–35) |
Cruz et al. (2018, 2020)181967
|
Pregnant and nonpregnant women (121) |
NR |
RYGB (Excluded some conditions)d
|
NR/Yese
|
43 (±SD 3) to 44 (±SD 6) |
30 (±SD 4) to 32 (±SD 4) |
Rosa et al. (2013)68
|
Women of childbearing age (56) |
NR |
RYGB |
NR/Yesf
|
46 (±SD 8) |
35 (±SD 9) |
Duran de Campos et al. (2008)39
|
Women of childbearing age (30) |
NR (excluded nonwhite) |
RYGB |
NR |
29 (±SD 2.3) to 47 (±SD 8.6) |
46 (±SD 3) |
de Oliveira et al. (2020)35
|
Adolescents (100) |
Nonwhite (54%) |
NR |
NR |
Normal weight (71%) |
15–17 (59%) |
Souza et al. (2019)40
|
Pregnant women (71) |
Dart (62%) |
Healthy |
NR/None |
NR |
26 (±SD 6) |
Delmonico et al. (2018)41
|
Women of childbearing age (20) |
NR |
Malignant breast lesions |
NR |
NR |
37 |
Prado et al. (2015)3
|
Postpartum women (226) |
White (52%) |
NR |
NR/Yes (97%) |
NR |
28 (range 20–44) |
Dutra et al. (2019)58
|
Postpartum women (126)g
|
NR |
Hypertension (23%) |
NR/Yes |
26 (±SD 6) to 27 (±SD 5) |
25 (±SD 7) to 26 (±SD 7) |
Ferreira et al. (2015)42
|
Women of childbearing age (73) |
White (68%) |
NR (Excluded some conditions)h
|
NR/None |
26 (±SD 1) |
32 (±SD 1) |
Flauzino et al. (2017)43
|
Women of childbearing age (205) |
Caucasian (71–78%)b
|
HIV+ |
Antiretroviral/None |
25 (±SD 0) to 26 (±SD 0)b
|
40 (±SD 1)b
|
Lepsch et al. (2017)60 and Figueiredo et al. (2017, 2018, 2020)616263
|
Pregnant women (199) |
Mixed (46%) |
NR (Excluded some conditions) |
None/None |
< 25 (60%) |
27 (±SD 6) |
Lopes et al. (2015)44
|
Adolescents (97) |
NR |
NR |
NR |
26 (±SD 9) |
16 (±SD 1) |
Lopes et al. (2016)45
|
Women of childbearing age (369) |
NR |
Infertility and control |
NR/None |
NR |
36 (±SD 4) to 37 (±SD 4) |
Machado et al. (2013)46
|
Pregnant women (49) |
NR |
HIV+ |
Antiretroviral/None |
Excessive gestational weight (35%) |
30 (±SD 7) |
Martins et al. (2018)37
|
Postpartum women (225) |
Dark (79%) |
Urinary tract infection (32%), hypertension (9%), GDM (1%), and bleeding (8%) |
NR/Yes (64%) |
Overweight or obesity (34%) |
26 (±SD 7) |
Medeiros et al. (2016)64
|
Pregnant women (46) |
NR |
RYGB |
NR/Yesi
|
28 to 44 (±SD 6) |
31 (±SD 5) |
Mendes et al. (2019)47
|
Women of childbearing age (79) |
White (63%) |
NR |
NR/None |
24 (±SD 5) |
Median: 27 (IQR 24–31) |
Menegati et al. (2016)17
|
Women of childbearing age (58) |
NR |
RYGB and control (obesity) (Excluded some conditions)j
|
NR/Yes (calcium) |
35 (CI 95% 33–37) to 52 (CI 95% 40–73) |
39 (CI 95% 36–42) to 40 (CI 95% 38–42) |
Pena et al. (2015)48
|
Pregnant and nonpregnant (179) |
Nonwhite (82%) |
Preeclampsia and gestational obesity |
NR |
IQR: 21–37 |
IQR: 19–33 |
Pereira-Santos (2014)49 and Pereira-Santos et al. (2018)50
|
Pregnant women (190) |
Nonblack (68%) |
NR (Excluded some conditions)k
|
NR/Yes (5%) |
Overweight (43%) |
18–29 (63%) |
Peters et al. (2009)51
|
Adolescents (71) |
NR (excluded nonwhite) |
NR (Excluded some conditions)l
|
NR |
22 (±SD 0) |
18 (±SD 1) |
Santos et al. (2013)52
|
Adolescents (198) |
NR |
Healthy |
NR/None |
Normal weight (76%) |
13 (±SD 2) |
Santos et al. (2017)53
|
Women of childbearing age (102) |
White (94%) |
Polycystic ovary syndrome and controls |
NR |
27 (±SD 6) to 30 (±SD 6) |
23 (±SD 7) to 25 (±SD 8) |
Santos et al. (2019)54
|
Women of childbearing age (61) |
Caucasian (80%) |
Healthy |
NR/Yes (calcium and vitamin D) |
29 (±SD 8) |
37 (±SD 11) |
Schtscherbyna et al. (2016)55
|
Adolescents and young adults (35) |
White (35%)b
|
HIV+ |
Antiretroviral/NR |
Normal (62%)b
|
Around 18 (±SD 2)b
|
Shinjo et al. (2011)56
|
Women of childbearing age (20) |
White (75%) |
Juvenile onset of systemic sclerosis and controls |
NR |
NR |
21 (±SD 2) to 21 (±SD 2) |
Simões et al. (2016)57
|
Postpartum women (99) |
Blacks or mulatto (58%) |
NR (Excluded some conditions)m
|
NR/Yes (9%) |
Overweight or obese (69%) |
26 (±SD 5) |
Weinert et al. (2014, 2016)6566
|
Pregnant women (184) |
White (74%) |
GDM (100%); Hypertension (22%) |
NR/None |
27 (±SD 5) to 30 (±SD 7) |
32 (±SD 6) |